New MAA: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma

xlomafota13 shared this article with you from Inoreader New MAA: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma Via Association française pour l'étude du cancer Bull Cancer. 2021 Oct 12:S0007-4551(21)00374-X. doi: 10.1016/j.bulcan.2021.07.010. Online ahead of print. NO ABSTRACT PMID:34654542 | DOI:10.1016/j.bulcan.2021.07.010 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.